Your browser doesn't support javascript.
loading
How low can you go?: Methodologic considerations in clonal hematopoiesis variant calling.
Beeler, J Scott; Bolton, Kelly L.
Afiliación
  • Beeler JS; Department of Medicine, Washington University School of Medicine, St. Louis, MO, USA.
  • Bolton KL; Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO, USA. Electronic address: bolton@wustl.edu.
Leuk Res ; 135: 107419, 2023 12.
Article en En | MEDLINE | ID: mdl-37956474
ABSTRACT
Clonal hematopoiesis (CH) is defined by the presence of an expanded clonal hematopoietic cell population due to an acquired mutation conferring a selective growth advantage and is known to predispose to hematologic malignancy. In this review, we discuss sequencing methods for CH detection in bulk sequencing data and corresponding bioinformatic approaches for variant calling, filtering, and curation. We detail practical recommendations for CH calling. Finally, we discuss how improvements in CH sequencing and bioinformatic approaches will enable the characterization of CH trajectories, its impact on human health, and therapeutic approaches to mitigate its adverse effects.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Hematológicas / Hematopoyesis Clonal Límite: Humans Idioma: En Revista: Leuk Res Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Hematológicas / Hematopoyesis Clonal Límite: Humans Idioma: En Revista: Leuk Res Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos